Biodegradable Stents in Primary Sclerosing Cholangitis
Recruiting
N/A
Interventional Study
Primary Sclerosing Cholangitis (PSC)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- King's College Hospital NHS Trust · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In patients with PSC, endoscopic therapy of strictures aims to improve cholestasis by relieving the biliary obstruction via endoscopic biliary dilatation with consideration of plastic stents in strictures refractory to dilatation due to the risk of pancreatitis and cholangitis . Short term stents have been shown to have similar recurrence-free rates compared to dilatation in a randomised control t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* PSC patients with a high grade stricture
Exclusion Criteria:
* Prior stenting or balloon dilatation within the previous 4 months
* Signs of bacterial cholangitis as defined by definite cholangitis
* Change of UDCA therapy within 4 weeks
* Inability to give informed consent
*…
Contacts
No contact information available.